Risk of gastrointestinal adverse events associated with chimeric antigen receptor T-cell therapy (CAR-T): A nationwide analysis

被引：0
|
作者：
Khan, Shahryar
Asif, Samia
Khan, Mashal Alam
Khan, Muhammad Atif
Amin, Muhammad Kashif
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS USA
[2] Univ Nebraska Med Ctr, Omaha, NE USA
[3] Khyber Med Univ, Peshawar, Pakistan
[4] Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Kansas City, KS USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19505
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
    Dhawale, Tejaswini
    Johnson, P. Connor
    Boateng, Kofi
    Barata, Anna
    Traeger, Lara
    Nelson, Ashley M.
    Lavoie, Mitchell W.
    Holmbeck, Katherine
    Choe, Joanna
    Nabily, Anisa
    Tripathi, Astha
    Amonoo, Hermioni L.
    Frigault, Matt
    El-Jawahri, Areej
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04): : 402.e1 - 402.e12
  • [2] Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy
    Abu-Sbeih, Hamzah
    Tang, Tenglong
    Ali, Faisal S.
    Luo, Wenyi
    Neelapu, Sattva S.
    Westin, Jason R.
    Okhuysen, Pablo C.
    Foo, Wai Chin
    Curry, Jonathan L.
    Richards, David M.
    Ge, Phillip S.
    Wang, Yinghong
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (10): : 789 - 796
  • [3] Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
    Brown, Kevin
    Seftel, Matthew D.
    Hay, Kevin A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (33) : E1300 - E1302
  • [4] Patterns of Failure Following Chimeric Antigen Receptor T-cell (CAR-T) Therapy
    Figura, N. B.
    Jain, M. D.
    Sim, A. J.
    Chavez, J. C.
    Shah, B. D.
    Khimani, F.
    Lazaryan, A.
    Liu, H. D.
    Kim, S.
    Locke, F. L.
    Robinson, T. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S66 - S67
  • [5] CHIMERIC ANTIGEN RECEPTOR T CELL (CAR-T) THERAPY IN CHILDREN
    Desai, Devarshi
    Aragon, Camila Gonzalez
    Pabon, Camila
    Sendi, Prithvi Raj
    Meyer, Keith
    Totapally, Balagangadhar
    CRITICAL CARE MEDICINE, 2024, 52
  • [6] Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy
    Goldman, Adam
    Maor, Elad
    Bomze, David
    Liu, Jennifer E.
    Herrmann, Joerg
    Fein, Joshua
    Steingart, Richard M.
    Mahmood, Syed S.
    Schaffer, Wendy L.
    Perales, Miguel-Angel
    Shouval, Roni
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (18) : 1800 - 1813
  • [7] Financial toxicity among chimeric antigen receptor T-cell therapy (CAR-T) patients
    Crowder, Sylvia
    Hoogland, Aasha
    Quast, Troy
    Turner, Kea
    Irizarry-Arroyo, Nathaly
    Rodriguez, Yvelise
    Logue, Jennifer
    Locke, Frederick
    Jim, Heather
    PSYCHO-ONCOLOGY, 2021, 30 : 37 - 37
  • [8] Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Pagel, John M.
    West, Howard
    JAMA ONCOLOGY, 2017, 3 (11) : 1595 - 1595
  • [9] Myocardial strain is associated with adverse cardiac events in patients treated with chimeric antigen receptor (CAR) T-cell therapy
    Patel, Nikita P.
    Dalal, Prarthana J.
    Meng, Zhiying
    Baldridge, Abigail S.
    Cascino, Gregory J.
    Sunderraj, Ashwin
    Sinha, Arjun
    Karmali, Reem
    Feinstein, Matthew J.
    Akhter, Nausheen
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (01) : 102 - 110
  • [10] Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies
    Cooper, Mathew L.
    DiPersio, John F.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (04)
12345